… The efficacy and safety of methylphenidate in attention deficit disorder: A systematic review
… Carvedilol for children and adolescents with heart failure: a randomized controlled trial[J]. …

… models have allowed scientists to determine the receptors, enzymes, and signaling pathways
that cannabinoids affect, and have supported the idea that cannabinoids are generally safe…

… ) raises questions about its safety in certain patients with cardiovascular risk factors. Moreover,
its … in the treatment of depression in Alzheimer disease patients: a systematic review and …

… intranasal spray esketamine (Spravato®) has shown effectiveness in alleviating depressive
symptoms in treatment-resistant depression patients (Sato et al., 2022; Zaki et al., 2023). …

… use amongpatients undergoing coronary artery bypass graft and valve surgeryin northwest
Iran. We evaluated the postoperative complicationsand in-hospital mortality of patients with …

… , renal, respiratory illnesses or other organic diseases; ⑤ were using aspirin, steroids,
nonsteroidal anti-inflammatory drugs, selective serotonin reuptake inhibitors, medication affecting …

… 治療焦慮症常用的一線藥物有選擇性血清素回收抑制劑 (Selective serotonin Reuptake
Inhibitors,簡稱SSRI),血清素-正腎上 腺素再回收抑制劑(Serotonin norepinephrine Reuptake Inhibitors…

… [Abstract] Objective To explore the effect of comprehensive nursing service in patients with
autoimmune encephalitis (AE). Methods 32 patients with AE were selected and treated in our …

… with early-stage Parkinson’s disease, and can often predate the diagnosis by years.
Therefore, olfactory dysfunction should be considered a reliable marker of the disease. However, …

… Thus, serotonergic therapy was considered as a potential treatment strategy for AD.
Another study showed that both selective serotonin reuptake inhibitor administration and …